Introduction {#s1}
============

The development of a solid tumor is considered a multi-step process in which several molecular checkpoints must be altered to generate a tumor from a normal cell [@pone.0001398-Hahn1]. The acquired capabilities of tumor cells include their ability to proliferate continuously ignoring apoptosis or growth-inhibitory signals, generating their own mitogenic signals. In advanced phases of tumor development, a neoangiogenesis process takes place and finally tumor cells acquire the capacity of tissue invasion and metastasize to other organs. Generally, it is admitted that most tumors acquire these characteristics through genome instability, telomere stabilization and disruption of regulatory circuits [@pone.0001398-Hahn2].

A recent theory suggests the existence of cancer stem cells (CSC), a subpopulation of cells with tumorigenic potential that is lacked in the rest of the cells within this tumor. CSC were reported for some tumor types including breast and lung cancer, leukemia and glioblastoma [@pone.0001398-Reya1], [@pone.0001398-Dalerba1]. However, there is a great ignorance about how the "acquired capabilities" of tumor cells would take place; directly on adult stem cells, or on differentiated cells that suffer a dedifferentiation process. In this regard, CSC share several features with adult stem cells such as self-renewal ability, asymmetric division, and differentiation potential [@pone.0001398-Pardal1].

Adult human mesenchymal stem cell spontaneous immortalization and transformation were recently reported by our group [@pone.0001398-Rubio1], supporting the hypothesis of the stem cell origin of CSC. Independent laboratories have confirmed these data, reporting similar results using MSC derived from human or murine bone marrow [@pone.0001398-Miura1]--[@pone.0001398-Li1]. In this regard, we have previously characterized the cellular sequence of steps necessary to transform a human MSC into a tumorigenic cell [@pone.0001398-Rubio1]. Following approximately 20 population doublings *in vitro*, mesenchymal stem cell cultures enter a senescence phase, but are able to bypass it at a high frequency. These cells then continue to divide until they reach a crisis phase. Only some samples are able to escape from this crisis phase spontaneously, but those that do have undergone tumorigenic transformation generating TMC.

However, until now genetic alterations implied in spontaneous MSC transformation are little known. Some groups have studied molecular pathways involved in the artificial transformation of MSC transduced with oncogenes [@pone.0001398-Funes1], [@pone.0001398-Serakinci1]. In this study, we have characterized the molecular mechanisms implicated in TMC generation and we propose a two-stage model by which a human MSC becomes *in vitro* a tumor cell.

Results {#s2}
=======

Comparative gene expression analysis of MSC transformation by microarray analysis {#s2a}
---------------------------------------------------------------------------------

To analyze molecular differences associated with TMC generation, we performed microarray studies using mRNA from pre- and post-senescence MSC, and from TMC. From a general perspective, data analysis showed that the greatest changes were associated with TMC generation, as TMC functions were more different than post-senescence MSC, compared to pre-senescence MSC ([Table 1](#pone-0001398-t001){ref-type="table"}). Although in a minor intensity, post-senescence MSC have the same altered functions that TMC. In both cases the principal category affected is "cancer" ([Table 1](#pone-0001398-t001){ref-type="table"}). However, the main pathways deregulated in both, post-senescence MSC and TMC, are related to stress, toxic events and mitochondrial metabolism ([Table 2](#pone-0001398-t002){ref-type="table"}). On the other hand, there was more down- than upregulated RNA transcripts associated with TMC generation ([Figure S1](#pone.0001398.s001){ref-type="supplementary-material"}). The main differences in mRNA expression profiles between pre- and post-senescence MSC are shown in [Table 3](#pone-0001398-t003){ref-type="table"}. [Table 4](#pone-0001398-t004){ref-type="table"} shows differences between pre-senescence MSC and TMC.

10.1371/journal.pone.0001398.t001

###### Comparative table of functions with a higher significance in selected genes for post-senescence MSC and TMC, obtained by Ingenuity Pathways Analysis software.
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  Category                          Process Annotation          pre-sen/post-sen MSC   pre-sen MSC/TMC             
  -------------------------- --------------------------------- ---------------------- ----------------- ---------- -----
  Cancer                               Tumorigenesis                  2.73E-18               22          4.71E-27   41
  Cellular Movement            Migration of eukaryotic cells          4.38E-07                9          1.74E-18   25
  Tissue Development          Developmental process of tissue         1.35E-07                9          1.35E-17   23
  Gastrointestinal Disease           Colorectal cancer                9.32E-12                9          1.75E-17   16
  Genetic Disorder                   Genetic disorder                 2.40E-05                8          2.74E-17   26
  Cell Death                  Cell death of eukaryotic cells          3.06E-11               16          6.73E-20   34
  Organismal Survival                Survival of mice                 3.14E-08                7            N/A      N/A
  Organismal Survival                Death of mammalia                1.84E-04                6          3.62E-11   17
  Neurological Disease             Cell death of neurons              4.71E-08                7          2.30E-05    7

In each category only the highest "Process Annotation" is represented.

10.1371/journal.pone.0001398.t002

###### Top tox list obtained by Ingenuity Pathways Analysis for post-senescence MSC and TMC.
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  MSC presen/MSCpost-sen                 p-value        Ratio
  ------------------------------------- ---------- ---------------
  Aryl Hydrocarbon Receptor Signaling    1.97E_05   4/154 (0.026)
  Hepatic fibrosis                       3.48E_03   2/85 (0.024)
  Xenobiotic Metabolism                  7.83E_03   2/129 (0.016)
  Cytochrome P450 Panel                  1.43E_02   1/14 (0.071)

  MSC presen/TMC                                    p-value        Ratio
  ------------------------------------------------ ---------- ---------------
  Hepatic fibrosis                                  2.11E_14   10/85 (0.118)
  FXF/RXR activation                                1.18E_03   2/20 (0.100)
  Mitochondrial dysfunction                         4.70E_03   3/125 (0.024)
  Hepatic cholestasis                               5.04E_03   3/125 (0.022)
  LPS & IL-1 mediated inhibition of RXR function    1.19E_02   3/185 (0.016)

10.1371/journal.pone.0001398.t003

###### Main mRNA differences between pre- and post-senescence MSC.
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  Genbank Acc No                                                 Gene name                                                 x-fold change   p-value   z-score
  ---------------- ------------------------------------------------------------------------------------------------------ --------------- --------- ---------
  NM_004932                                    Cadherin 6, type 2, K-cadherin (fetal kidney)                                  −3.675       \<0.001   −8.612
  AL049227                            Homo sapiens mRNA; cDNA DKFZp564N1116 (from clone DKFZp564N1116)                        −3.173       \<0.001   −8.827
  NM_021197                                           WAP four-disulfide core domain 1                                        −3.151        0.005    −8.772
  NM_003012                                         Secreted frizzled-related protein 1                                       −3.048        0.001    −6.866
  AF070524                                         Homo sapiens clone 24453 mRNA sequence                                     −2.664        0.006    −6.775
  AB046796                                                    KIAA1576 protein                                                −2.346        0.004    −4.803
  NM_013381                                  Thyrotropin-releasing hormone degrading ectoenzyme                               −2.272        0.004    −5.253
  AK022997                                   Homo sapiens cDNA FLJ12935 fis. clone NT2RP2004982                               −2.265        0.003    −5.048
  NM_006208                                  Ectonucleotide pyrophosphatase/phosphodiesterase 1                               −2.259        0.003    −4.791
  NM_033211                                  Hypothetical gene supported by AF038182; BC009203                                −2.220        0.001    −4.689
  AJ279081                                          Chromosome 21 open reading frame 66                                       −2.188       \<0.001   −4.726
  NM_006389                                           Oxygen regulated protein (150kD)                                        −2.173        0.009    −4.402
  NM_000627                               Latent transforming growth factor beta binding protein 1                            −2.094       \<0.001   −4.554
  NM_001271                                     Chromodomain helicase DNA binding protein 2                                   −2.076        0.006    −6.785
  NM_002937                                           Ribonuclease. RNase A family. 4                                         −2.016       \<0.001   −3.940
  NM_000325                                    Paired-like homeodomain transcription factor 2                                 −1.959       \<0.001   −3.954
  NM_000930                                            Plasminogen activator. tissue                                          −1.930        0.001    −4.655
  AK057782                                     Homo sapiens cDNA FLJ25053 fis. clone CBL04266                                 −1.908        0.002    −5.726
  NM_005382                                            Neurofilament 3 (150kD medium)                                         −1.884        0.001    −3.872
  U67784                                                 G protein-coupled receptor                                           −1.855       \<0.001   −3.732
  NM_021730                                             Hypothetical protein PP1044                                           −1.833        0.002    −3.514
  NM_002977                              Sodium channel. voltage-gated. type IX. alpha polypeptide                            −1.823        0.000    −3.512
  NM_032883                                         Chromosome 20 open reading frame 100                                      −1.804        0.005    −3.561
  NM_004405                                               Distal-less homeo box 2                                             −1.788        0.009    −4.443
  AF263545                                    Homo sapiens HUT11 protein mRNA. partial 3′ UTR                                 −1.776        0.007    −5.334
  D13628                                                       Angiopoietin 1                                                 −1.748       \<0.001   −4.393
  NM_031957                                            Keratin associated protein 1.5                                         −1.738        0.001    −4.048
  BC012486                                          Keratin associated protein KRTAP2.1A                                      −1.732       \<0.001   −3.517
  NM_021226                                   Hypothetical protein from clones 23549 and 23762                                −1.694        0.007    −3.864
  NM_000077                         Cyclin-dependent kinase inhibitor 2A (melanoma. p16. inhibits CDK4)                       −1.686        0.003    −4.109
  AF070641                                         Homo sapiens clone 24421 mRNA sequence                                     −1.660        0.007    −4.773
  NM_004288                          Pleckstrin homology. Sec7 and coiled/coil domains. binding protein                       −1.636        0.009    −4.299
  NM_018476                                             Brain expressed. X-linked 1                                           −1.524       \<0.001   −3.971
  AF161403                                         Homo sapiens HSPC285 mRNA. partial cds                                      1.507        0.001     3.846
  NM_019111                                 Major histocompatibility complex. class II. DR alpha                               1.598       \<0.001    3.582
  AP001660                                Homo sapiens genomic DNA. chromosome 21q. section 4/105                              1.654        0.003     4.720
  AK022034                                   Homo sapiens cDNA FLJ11972 fis. clone HEMBB1001209                                1.667        0.008     3.744
  NM_005435                                    Rho guanine nucleotide exchange factor (GEF) 5                                  1.687       \<0.001    4.854
  NM_024081                                  Transmembrane gamma-carboxyglutamic acid protein 4                                1.733       \<0.001    4.446
  NM_004938                                          Death-associated protein kinase 1                                         1.776        0.008     5.389
  NM_004962                                           Growth differentiation factor 10                                         1.817        0.004     5.410
  NM_000900                                                  Matrix Gla protein                                                1.828        0.003     5.265
  NM_012068                                          Activating transcription factor 5                                         1.832        0.002     3.701
  NM_014424                              Heat shock 27kD protein family. member 7 (cardiovascular)                             1.855        0.004     3.603
  NM_022719         DiGeorge syndrome critical region gene DGSI; likely ortholog of mouse expressed sequence 2 embryonic       1.879        0.003     3.887
  NM_004669                                           Chloride intracellular channel 3                                         1.889        0.006     4.662
  NM_001673                                                Asparagine synthetase                                               1.896        0.006     3.594
  NM_000095             Cartilage oligomeric matrix protein (pseudoachondroplasia. epiphyseal dysplasia 1. multiple)           1.921       \<0.001    3.665
  NM_001353         Aldo-keto reductase family 1. member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxyster       1.947       \<0.001    3.742
  NM_019105                                                     Tenascin XB                                                    2.036        0.001     4.471
  AB046843                                                    KIAA1623 protein                                                 2.040        0.001     5.225
  AF111170                            Homo sapiens 14q32 Jagged2 gene. complete cds; and unknown gene                          2.051       \<0.001    4.030
  NM_007223                                         Putative G protein coupled receptor                                        2.126        0.006     6.832
  AK057721                                   Homo sapiens cDNA FLJ33159 fis. clone UTERU2000465                                2.134        0.002     5.097
  NM_003480                                        Microfibril-associated glycoprotein-2                                       2.307        0.002     4.891
  AK024396                                   Acetyl-Coenzyme A synthetase 2 (AMP forming)-like                                 2.330        0.002     6.343
  BC015794                                             Hypothetical protein FLJ10097                                           2.367       \<0.001    5.142
  AK024428                                  Pleckstrin homology. Sec7 and coiled/coil domains 4                                2.415        0.007     6.613
  AK024240                                   Homo sapiens cDNA FLJ14178 fis. clone NT2RP2003339                                2.451        0.001     6.199
  NM_005264                                             GDNF family receptor alpha 1                                           2.465       \<0.001    6.065
  L48728                              Homo sapiens T cell receptor beta (TCRBV10S1) gene. complete cds                         2.626        0.004     7.592
  NM_005556                                                      Keratin 7                                                     2.795        0.007     5.917
  NM_007281                                             Scrapie responsive protein 1                                           2.828       \<0.001    6.276
  NM_005596                                                  Nuclear factor I/B                                                2.844       \<0.001    6.389
  NM_004750                                           Cytokine receptor-like factor 1                                          3.027       \<0.001    6.610
  AK055188           Homo sapiens cDNA FLJ30626 fis. clone CTONG2001911. weakly similar to UBIQUITIN CARBOXYL-TERMINAL         3.340        0.002     7.033
  AF311912                                          Secreted frizzled-related protein 2                                        3.365        0.001     7.630
  AL080218                            Homo sapiens mRNA; cDNA DKFZp586N1323 (from clone DKFZp586N1323)                         3.422        0.002     7.428
  U14383                                                 Mucin 8. tracheobronchial                                             3.791        0.004     7.836
  NM_000095             Cartilage oligomeric matrix protein (pseudoachondroplasia. epiphyseal dysplasia 1. multiple)           3.796        0.003     7.483
  AK000819                                    Homo sapiens cDNA FLJ20812 fis. clone ADSE01316                                  3.953       \<0.001    8.800
  NM_015863                                                 Surfactant protein B                                               4.343       \<0.001   13.305
  NM_005532                                        Interferon. alpha-inducible protein 27                                      5.236       \<0.001   12.417

Array data were filtered according to Z-score (\>3.5 and \<−3.5) and p-value (\<0.01).

10.1371/journal.pone.0001398.t004

###### Main mRNA differences between pre-senescence MSC and TMC.
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  Genbank Acc No.                                                 Gene name                                                 x-fold change   p-value   z-score
  ----------------- ------------------------------------------------------------------------------------------------------ --------------- --------- ---------
  NM_000165                                   Gap junction protein, alpha 1, 43kD (connexin 43)                                −52.904      \<0.001   −6.640
  BC014245           Homo sapiens, Similar to RIKEN cDNA 1110014B07 gene, clone MGC:20766 IMAGE:4586039, mRNA, complete c      −45.496      \<0.001   −6.311
  NM_000089                                               Collagen, type I, alpha 2                                            −44.113      \<0.001   −6.041
  NM_002421                                 Matrix metalloproteinase 1 (interstitial collagenase)                              −31.671      \<0.001   −5.512
  NM_006475                                    Osteoblast specific factor 2 (fasciclin I-like)                                 −31.206      \<0.001   −5.513
  NM_052947                                                   Heart alpha-kinase                                               −30.941      \<0.001   −5.499
  NM_000089                                               Collagen, type I, alpha 2                                            −30.183      \<0.001   −5.443
  NM_002937                                            Ribonuclease, RNase A family, 4                                         −30.113      \<0.001   −5.911
  NM_013372                                     Cysteine knot superfamily 1, BMP antagonist 1                                  −27.678      \<0.001   −5.301
  NM_006475                                    Osteoblast specific factor 2 (fasciclin I-like)                                 −25.377      \<0.001   −5.225
  NM_006063                                               Sarcomeric muscle protein                                            −25.291      \<0.001   −5.502
  M96843                                        Striated muscle contraction regulatory protein                                 −24.615      \<0.001   −5.414
  NM_002526                                                 5′ nucleotidase (CD73)                                             −24.069      \<0.001   −5.258
  NM_021242                                            Hypothetical protein STRAIT11499                                        −22.708      \<0.001   −6.307
  AK027274                                    Homo sapiens cDNA FLJ14368 fis, clone HEMBA1001122                               −21.750      \<0.001   −7.398
  AB033025                                                     KIAA1199 protein                                                −21.257      \<0.001   −4.880
  NM_032348                                              Hypothetical protein MGC3047                                          −20.763      \<0.001   −4.840
  NM_000963                 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)              −20.328      \<0.001   −5.091
  AB058761                                                     KIAA1858 protein                                                −20.016      \<0.001   −5.644
  NM_006211                                                     Proenkephalin                                                  −19.361      \<0.001   −4.731
  AK055725                                                  Maternally expressed 3                                             −19.350      \<0.001   −4.747
  NM_000138                                             Fibrillin 1 (Marfan syndrome)                                          −18.750      \<0.001   −4.679
  AB011145                                                     KIAA0573 protein                                                −18.677      \<0.001   −5.912
  NM_006988              A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1          −18.388      \<0.001   −4.649
  AB014511                                                ATPase, Class II, type 9A                                            −17.675      \<0.001   −4.701
  NM_000393                                               Collagen, type V, alpha 2                                            −17.533      \<0.001   −4.628
  NM_000419                   Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)                −17.439      \<0.001   −5.061
  NM_007268                                                 Ig superfamily protein                                             −17.320      \<0.001   −4.951
  NM_015696                                       Weakly similar to glutathione peroxidase 2                                   −16.943      \<0.001   −4.525
  NM_016651                                      Heptacellular carcinoma novel gene-3 protein                                  −16.524      \<0.001   −4.966
  NM_002593                                          Procollagen C-endopeptidase enhancer                                      −16.332      \<0.001   −4.476
  NM_000358                                     Transforming growth factor, beta-induced, 68kD                                 −16.120      \<0.001   −4.438
  NM_031442                                             Brain cell membrane protein 1                                          −15.709      \<0.001   −4.508
  NM_015364                                                      MD-2 protein                                                  −15.455      \<0.001   −4.753
  NM_002487                                                 Necdin homolog (mouse)                                             −15.122      \<0.001   −5.116
  AF109681                                                    Integrin, alpha 11                                               −15.057      \<0.001   −4.708
  NM_000916                                                   Oxytocin receptor                                                −14.278      \<0.001   −4.260
  AL136693                                                  Duodenal cytochrome b                                              −14.265      \<0.001   −4.350
  AK055976                                              Thymosin, beta 4, X chromosome                                         −14.159      \<0.001   −4.233
  AK025931                                     Homo sapiens cDNA: FLJ22278 fis, clone HRC03745                                 −13.834      \<0.001   −4.949
  BC000257                                   Homo sapiens, clone IMAGE:3357862, mRNA, partial cds                              −13.804      \<0.001   −4.193
  NM_007085                                                   Follistatin-like 1                                               −13.508      \<0.001   −4.164
  NM_022726                     Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4                 −12.892      \<0.001   −4.526
  NM_005847                              Solute carrier family 23 (nucleobase transporters), member 2                          −12.779      \<0.001   −4.511
  NM_030781                                             Collectin sub-family member 12                                         −12.550      \<0.001   −5.284
  NM_000093                                               Collagen, type V, alpha 1                                            −12.506      \<0.001   −4.033
  NM_001353          Aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxyster      −12.332      \<0.001   −4.011
  NM_002064                                            Glutaredoxin (thioltransferase)                                         −12.314      \<0.001   −4.005
  NM_020404                                          Tumor endothelial marker 1 precursor                                      −12.138      \<0.001   −4.086
  NM_000962                 Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)              −11.886      \<0.001   −4.382
  NM_022360                                            Human epididymis-specific 3 beta                                        −11.816       0.001    −4.766
  BC009078                             Homo sapiens, clone MGC:17624 IMAGE:3855543, mRNA, complete cds                         −11.792      \<0.001   −4.284
  AB051443                                                     KIAA1656 protein                                                −11.742      \<0.001   −7.230
  NM_031440                                                Transmembrane protein 7                                             −11.686      \<0.001   −5.635
  NM_002421                                 Matrix metalloproteinase 1 (interstitial collagenase)                              −11.641      \<0.001   −3.918
  NM_024031                                              Hypothetical protein MGC3121                                          −11.606      \<0.001   −3.916
  AF200348                                                 Melanoma associated gene                                            −11.516      \<0.001   −3.901
  NM_031426                                             Hypothetical protein FLJ12783                                          −11.244      \<0.001   −3.923
  AK055903                                     Homo sapiens cDNA: FLJ21592 fis, clone COL07036                                 −11.134      \<0.001   −3.847
  NM_012104                                             Beta-site APP-cleaving enzyme                                          −10.628      \<0.001   −3.819
  AL133640                      Homo sapiens mRNA; cDNA DKFZp586C1021 (from clone DKFZp586C1021); partial cds                  −10.618      \<0.001   −4.345
  U17077                                                         BENE protein                                                  −10.516      \<0.001   −4.085
  NM_024563                                             Hypothetical protein FLJ14054                                          −10.297      \<0.001   −4.710
  NM_004098                                         Empty spiracles homolog 2 (Drosophila)                                     −10.242      \<0.001   −3.715
  AK023413           Homo sapiens cDNA FLJ13351 fis, clone OVARC1002156, weakly similar to Danio rerio uridine kinase mRN      −10.209      \<0.001   −4.692
  NM_000090                    Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)                −10.049      \<0.001   −3.684
  NM_003247                                                    Thrombospondin 2                                                −9.958       \<0.001   −3.667
  NM_005086                                       Sarcospan (Kras oncogene-associated gene)                                    −9.955       \<0.001   −4.800
  NM_004265                                                Fatty acid desaturase 2                                             −9.904       \<0.001   −3.660
  NM_014244              A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 2          −9.728       \<0.001   −4.028
  AF131817                                          Homo sapiens clone 25023 mRNA sequence                                     −9.691       \<0.001   −4.916
  AK054816                                              Ferritin, heavy polypeptide 1                                          −9.653       \<0.001   −3.629
  AL050370                             Homo sapiens mRNA; cDNA DKFZp566C0546 (from clone DKFZp566C0546)                        −9.494        0.001    −4.871
  NM_003246                                                    Thrombospondin 1                                                −9.217       \<0.001   −3.635
  NM_004660                               DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide, Y chromosome                           −9.185       \<0.001   −3.666
  NM_014678                                                 KIAA0685 gene product                                              −9.118       \<0.001   −3.584
  NM_016588                                                        Neuritin                                                    −8.963       \<0.001   −4.233
  NM_001235                  Serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), member 2              −8.923       \<0.001   −3.503
  AK057865                                                Thy-1 cell surface antigen                                           −8.798       \<0.001   −4.707
  NM_023927                                             Hypothetical protein FLJ21313                                          −8.689       \<0.001   −3.574
  NM_013253                                          Dickkopf homolog 3 (Xenopus laevis)                                       −8.612       \<0.001   −4.497
  AF111170                             Homo sapiens 14q32 Jagged2 gene, complete cds; and unknown gene                         −8.553       \<0.001   −3.800
  AF334710               Homo sapiens pyruvate dehydrogenase kinase 4 mRNA, 3′ untranslated region, partial sequence           −8.534        0.001    −4.138
  NM_022143                                                     NAG14 protein                                                  −8.469       \<0.001   −3.575
  NM_002422                               Matrix metalloproteinase 3 (stromelysin 1, progelatinase)                            −8.442        0.001    −3.777
  AK055249                                    Homo sapiens cDNA FLJ30687 fis, clone FCBBF2000379                               −8.415       \<0.001   −3.917
  AJ279081                                           Chromosome 21 open reading frame 66                                       −8.329       \<0.001   −4.091
  NM_001541                                               Heat shock 27kD protein 2                                            −8.279       \<0.001   −3.537
  NM_017680                                                 Asporin (LRR class 1)                                              −8.279       \<0.001   −5.816
  NM_004418                                             Dual specificity phosphatase 2                                         −8.249       \<0.001   −4.407
  AL049227                             Homo sapiens mRNA; cDNA DKFZp564N1116 (from clone DKFZp564N1116)                        −8.230       \<0.001   −4.831
  NM_031897                                  Calcium channel, voltage-dependent, gamma subunit 6                               −8.127       \<0.001   −5.033
  AY040094                                                  Serine protease HTRA3                                              −7.690       \<0.001   −4.676
  NM_002761                                                      Protamine 1                                                   −7.636       \<0.001   −3.924
  NM_001850                                              Collagen, type VIII, alpha 1                                          −7.617       \<0.001   −3.919
  AB011538                                               Slit homolog 3 (Drosophila)                                           −7.569       \<0.001   −3.813
  AB033073                                           Similar to glucosamine-6-sulfatases                                       −7.473        0.001    −3.627
  NM_003885                                 Cyclin-dependent kinase 5, regulatory subunit 1 (p35)                              −7.415       \<0.001   −4.046
  NM_030786                                        Intermediate filament protein syncoilin                                     −7.325       \<0.001   −3.751
  NM_001864                                Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle)                            −7.295       \<0.001   −3.654
  AK001058                                    Homo sapiens cDNA FLJ10196 fis, clone HEMBA1004776                               −7.238       \<0.001   −3.569
  NM_001375                                            Deoxyribonuclease II, lysosomal                                         −7.202       \<0.001   −3.719
  NM_002414                             Antigen identified by monoclonal antibodies 12E7, F21 and O13                          −7.199       \<0.001   −3.630
  AL080135                                            Hypothetical protein DKFZp434I143                                        −7.174       \<0.001   −4.265
  BF680501                                                Putative membrane protein                                            −7.108       \<0.001   −6.487
  NM_017980                                             Hypothetical protein FLJ10044                                          −6.999       \<0.001   −3.665
  M68874                                  Phospholipase A2, group IVA (cytosolic, calcium-dependent)                           −6.795       \<0.001   −5.273
  NM_006552                                        Lipophilin A (uteroglobin family member)                                    −6.550       \<0.001   −3.540
  AK054724                                    Homo sapiens cDNA FLJ30162 fis, clone BRACE2000565                               −6.401       \<0.001   −3.877
  AK025015                                     Homo sapiens cDNA: FLJ21362 fis, clone COL02886                                 −6.389       \<0.001   −3.580
  NM_002776                                                     Kallikrein 10                                                  −6.375       \<0.001   −3.741
  AF380356                                           Homo sapiens PBDX mRNA, complete cds                                      −6.263       \<0.001   −4.673
  NM_004529             Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3         −6.221        0.003    −4.190
  NM_025258                                                      NG37 protein                                                  −6.045        0.002    −4.951
  BC016964                             Homo sapiens, clone MGC:21621 IMAGE:4181577, mRNA, complete cds                         −5.945       \<0.001   −4.086
  AK022198                                    Homo sapiens cDNA FLJ12136 fis, clone MAMMA1000312                               −5.889        0.008    −4.879
  AK056857              Homo sapiens cDNA FLJ32295 fis, clone PROST2001823, weakly similar to TRANSCRIPTION FACTOR SP1         −5.879        0.001    −4.255
  NM_032514                                  Microtubule-associated protein 1 light chain 3 alpha                              −5.830       \<0.001   −4.491
  AK024734                                     Homo sapiens cDNA: FLJ21081 fis, clone CAS02959                                 −5.816       \<0.001   −4.229
  BC017981           Homo sapiens, Similar to RIKEN cDNA 2700038C09 gene, clone MGC:24600 IMAGE:4245342, mRNA, complete c      −5.685        0.001    −3.761
  AF220030                                              Tripartite motif-containing 6                                          −5.666       \<0.001   −4.166
  NM_001458                                      Filamin C, gamma (actin binding protein 280)                                  −5.649       \<0.001   −3.748
  AK025786                                     Homo sapiens cDNA: FLJ22133 fis, clone HEP20529                                 −5.544       \<0.001   −3.707
  NM_001935                        Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2)                     −5.426       \<0.001   −4.964
  AF131851                                                   Hypothetical protein                                              −5.282       \<0.001   −5.808
  NM_031957                                             Keratin associated protein 1.5                                         −5.278       \<0.001   −3.813
  AK057853                                      Homo sapiens cDNA FLJ25124 fis, clone CBR06414                                 −5.132       \<0.001   −5.054
  BC004224                              Homo sapiens, clone MGC:4762 IMAGE:3537945, mRNA, complete cds                         −5.044       \<0.001   −4.122
  NM_000451                                                 Short stature homeobox                                             −4.956       \<0.001   −3.845
  U12767                                       Nuclear receptor subfamily 4, group A, member 3                                 −4.840       \<0.001   −4.340
  NM_006517              Solute carrier family 16 (monocarboxylic acid transporters), member 2 (putative transporter)          −4.815       \<0.001   −4.004
  NM_018692                                          Chromosome 20 open reading frame 17                                       −4.722       \<0.001   −5.134
  NM_005130                                     Heparin-binding growth factor binding protein                                  −4.683        0.004    −6.093
  AK026141            Homo sapiens cDNA: FLJ22488 fis, clone HRC10948, highly similar to HSU79298 Human clone 23803 mRNA       −4.639       \<0.001   −3.517
  AK055391           Homo sapiens cDNA FLJ30829 fis, clone FEBRA2001790, highly similar to Xenopus laevis RRM-containing       −4.535       \<0.001   −5.706
  AL359052                            Homo sapiens mRNA full length insert cDNA clone EUROIMAGE 1968422                        −4.486       \<0.001   −3.606
  NM_003012                                          Secreted frizzled-related protein 1                                       −4.471        0.002    −3.815
  BC015134                                         Homo sapiens, clone IMAGE:3934391, mRNA                                     −4.455        0.005    −4.111
  AK055501                                    Homo sapiens cDNA FLJ30939 fis, clone FEBRA2007414                               −4.436       \<0.001   −3.795
  AF000994                           Ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome                      −4.392       \<0.001   −4.574
  NM_002089                                                     GRO2 oncogene                                                  −4.319       \<0.001   −4.839
  NM_018271                                             Hypothetical protein FLJ10916                                          −4.274       \<0.001   −5.289
  NM_006030                              Calcium channel, voltage-dependent, alpha 2/delta subunit 2                           −4.269        0.005    −5.657
  NM_052969                                               Ribosomal protein L39-like                                           −4.156       \<0.001   −3.920
  NM_022773                                             Hypothetical protein FLJ12681                                          −4.146       \<0.001   −4.175
  NM_004753                                         Short-chain dehydrogenase/reductase 1                                      −4.134       \<0.001   −4.386
  D13628                                                        Angiopoietin 1                                                 −4.075        0.003    −5.116
  NM_004675                                           Ras homolog gene family, member I                                        −4.027        0.001    −3.549
  NM_001532                              Solute carrier family 29 (nucleoside transporters), member 2                          −4.009       \<0.001   −3.537
  U16306                                        Chondroitin sulfate proteoglycan 2 (versican)                                  −3.959       \<0.001   −3.505
  NM_024806                                             Hypothetical protein FLJ23554                                          −3.806       \<0.001   −3.678
  AF152529                                      Protocadherin gamma subfamily B, 8 pseudogene                                  −3.770        0.003    −4.390
  NM_006383                          DNA-dependent protein kinase catalytic subunit-interacting protein 2                      −3.676        0.001    −4.543
  NM_020169                                                    Latexin protein                                                 −3.670       \<0.001   −3.817
  AK055969                                    Homo sapiens cDNA FLJ31407 fis, clone NT2NE2000137                               −3.494        0.006    −4.646
  BC011406                              Homo sapiens, clone MGC:9758 IMAGE:3855620, mRNA, complete cds                         −3.281       \<0.001   −3.672
  NM_014553                                      LBP protein; likely ortholog of mouse CRTR-1                                  −3.266        0.001    −4.130
  NM_006821                                      Peroxisomal long-chain acyl-coA thioesterase                                  −3.221       \<0.001   −3.869
  NM_005098                                          Musculin (activated B-cell factor-1)                                      −3.198        0.002    −4.057
  AK022355                                    Homo sapiens cDNA FLJ12293 fis, clone MAMMA1001815                               −3.178        0.004    −4.693
  NM_003178                                                      Synapsin II                                                   −3.130        0.001    −3.982
  U14383                                                  Mucin 8, tracheobronchial                                            −3.043        0.009    −4.336
  NM_004257                                        TGF beta receptor associated protein -1                                     −3.028        0.006    −4.330
  AK021632                                    Homo sapiens cDNA FLJ11570 fis, clone HEMBA1003309                               −2.987        0.009    −3.984
  NM_002108                                                Histidine ammonia-lyase                                             −2.982       \<0.001   −3.812
  NM_032880                                             Hypothetical protein MGC15730                                          −2.956        0.001    −3.585
  BC015160                                   Homo sapiens, clone IMAGE:3885940, mRNA, partial cds                              −2.873        0.004    −3.919
  AK055509                                    Homo sapiens cDNA FLJ30947 fis, clone FEBRA2007714                               −2.829       \<0.001   −3.925
  D86964                                                 Dedicator of cyto-kinesis 2                                           −2.801        0.002    −3.595
  NM_000639                                  Tumor necrosis factor (ligand) superfamily, member 6                              −2.731        0.005    −3.872
  NM_004694                         Solute carrier family 16 (monocarboxylic acid transporters), member 6                      −2.681        0.005    −3.662
  AB007964                                                         KIAA0495                                                    −2.677        0.001    −3.586
  X68994                                                 H.sapiens CREB gene, exon Y                                           −2.654        0.004    −3.554
  NM_013227          Aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified b      −2.628        0.007    −3.646
  AF019226                                                Glioblastoma overexpressed                                           −2.411        0.006    −3.507
  AK054905                                    Homo sapiens cDNA FLJ30343 fis, clone BRACE2007502                                1.931        0.006     4.281
  AF339768                                      Homo sapiens clone IMAGE:119716, mRNA sequence                                  2.544        0.004     3.639
  NM_000361                                                     Thrombomodulin                                                  2.620        0.001     3.636
  NM_006187                                       2′-5′-oligoadenylate synthetase 3 (100 kD)                                    2.628        0.007     3.724
  AK025390                                     Homo sapiens cDNA: FLJ21737 fis, clone COLF3396                                  2.772        0.001     3.713
  AF130074                                  Homo sapiens clone FLB9348 PRO2523 mRNA, complete cds                               2.805        0.001     4.057
  AB032962                                                     KIAA1136 protein                                                 2.838        0.001     4.111
  AJ420570                                    Homo sapiens cDNA FLJ14752 fis, clone NT2RP3003071                                2.870       \<0.001    3.839
  NM_014811                                                 KIAA0649 gene product                                               2.873        0.007     4.113
  NM_004171                     Solute carrier family 1 (glial high affinity glutamate transporter), member 2                   2.950        0.008     4.227
  NM_013982                                                      Neuregulin 2                                                   2.985        0.001     3.982
  NM_032808                                             Hypothetical protein FLJ14594                                           3.020       \<0.001    4.172
  AB002366                                                     KIAA0368 protein                                                 3.085        0.009     4.403
  NM_018700                                             Tripartite motif-containing 36                                          3.129        0.001     4.306
  BC003376                        ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)                    3.172       \<0.001    3.568
  AK023283                                    Homo sapiens cDNA FLJ13221 fis, clone NT2RP4002075                                3.221       \<0.001    3.869
  AK054766                                    Homo sapiens cDNA FLJ30204 fis, clone BRACE2001496                                3.329        0.001     3.717
  NM_002829                                   Protein tyrosine phosphatase, non-receptor type 3                                 3.429       \<0.001    3.617
  NM_001618                              ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)                            3.444        0.001     4.504
  NM_001445                                   Fatty acid binding protein 6, ileal (gastrotropin)                                3.450        0.001     4.096
  NM_024565                                             Hypothetical protein FLJ14166                                           3.528        0.002     3.896
  L05148                                      Zeta-chain (TCR) associated protein kinase (70 kD)                                3.599       \<0.001    3.759
  NM_005525                                        Hydroxysteroid (11-beta) dehydrogenase 1                                     3.601       \<0.001    3.525
  NM_016931                                                    NADPH oxidase 4                                                  3.657        0.004     4.289
  AK057339                                                    Actin like protein                                                3.693       \<0.001    4.038
  NM_024771                                             Hypothetical protein FLJ13848                                           3.881        0.001     5.345
  NM_032047                             UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5                           4.172        0.002     4.415
  NM_014962                                             BTB (POZ) domain containing 3                                           4.237        0.002     5.362
  NM_017780                                                    KIAA1416 protein                                                 4.243       \<0.001    3.977
  AB018295                                                     KIAA0752 protein                                                 4.556       \<0.001    5.016
  NM_006622                                                 Serum-inducible kinase                                              4.639        0.001     4.742
  NM_003651                                              Cold shock domain protein A                                            4.961       \<0.001    4.080
  AF268419                                     Homo sapiens chondrosarcoma CSAG1c mRNA sequence                                 5.423       \<0.001    3.659
  AK055111           Homo sapiens cDNA FLJ30549 fis, clone BRAWH2001484, weakly similar to POLYPEPTIDE N-ACETYLGALACTOSAM       5.503       \<0.001    3.909
  NM_006597                                               Heat shock 70kD protein 8                                             5.664        0.001     3.622
  NM_019844                             Solute carrier family 21 (organic anion transporter), member 8                          5.919        0.000     4.271
  AB037727                                                Cask-interacting protein 1                                            7.351       \<0.001    3.597
  AL137311                     Homo sapiens mRNA; cDNA DKFZp761G02121 (from clone DKFZp761G02121); partial cds                  8.238       \<0.001    3.661
  BC014584                                         Homo sapiens, clone IMAGE:4047062, mRNA                                      8.280        0.001     3.982
  NM_003785                                      G antigen, family B, 1 (prostate associated)                                   8.326       \<0.001    3.582
  NM_005010                                            Neuronal cell adhesion molecule                                          8.533       \<0.001    4.478
  NM_033642                                              Fibroblast growth factor 13                                            9.666       \<0.001    4.016
  NM_018476                                              Brain expressed, X-linked 1                                           11.140       \<0.001    3.946
  NM_002364                                             Melanoma antigen, family B, 2                                          12.281       \<0.001    4.005

Array data were filtered according to Z-score (\>3.5 and \<−3.5) and p-value (\<0.01).

Molecular differences in cell cycle-related proteins {#s2b}
----------------------------------------------------

We had reported differences in cell cycle progression in pre- and post-senescence MSC and TMC, including more rapid cell division in TMC [@pone.0001398-Rubio1]. Here we used microarray techniques to explore the cell cycle-related molecular differences in post-senescence MSC and TMC compared to pre-senescence MSC. Compared to pre-senescence MSC, post-senescence MSC showed few differences in cell cycle-related proteins. In contrast, TMC samples showed significant mRNA modulations; Cdk1 and Cdk4 as well as cyclins B1 and D2 were upregulated, whereas cyclin D1 was downregulated ([Figure 1A](#pone-0001398-g001){ref-type="fig"}).

![Cell cycle regulation.\
(A) *x-fold* change, p-value and Z-score of cell cycle regulators expression measured by microarray analysis between pre- and post-senescence MSC and post-senescence MSC and TMC. (B) Relative mRNA expression of Cyclin D1 (CCND1), and cyclin-dependent kinases 2 (CDK2) and 6 (CDK6) in pre- and post-senescence MSC, TMC and met-TMC analyzed by qRT-PCR. (C) Western blot analysis of cell cycle regulator protein expression in pre- and post-senescence MSC and two TMC samples. α-tubulin was used as loading control.](pone.0001398.g001){#pone-0001398-g001}

We evaluated microarray experiments analyzed by qRT-PCR the expression of some of these genes. No expression difference was found between pre- and post-senescent MSC, while TMC overexpressed Cdk2 and Cdk6 ([Figure 1B](#pone-0001398-g001){ref-type="fig"}). In qRT-PCR experiments we also studied met-TMC, a cell line derived of lung metastases generated after s.c. inoculation of TMC in immunodeficient mice (Rubio *et al*, unpublished results).

To determine whether the differences in mRNA levels gave rise to altered protein expression, we compared these samples by western blot. In TMC, cyclin B1, Cdk2 and Cdk6 were upregulated, whereas Cdk1 and Cdk4 remained constant. Cyclin D1 was downregulated from pre-senescence MSC to TMC ([Figure 1C](#pone-0001398-g001){ref-type="fig"}).

Upregulation of DNA repair pathways in transformed MSC {#s2c}
------------------------------------------------------

As DNA repair mechanisms are responsible for the bypass of senescence and crisis, as well as for tumor maintenance and progression [@pone.0001398-Kastan1], we analyzed the major proteins linked to these processes. We tested proteins involved in pathways including non-homologous end joining (NHEJ), base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), and homologous recombination (HR).

Microarray analysis showed no mRNA significant differences between pre- and post-senescence MSC ([Figure 2A](#pone-0001398-g002){ref-type="fig"}). However protein analysis showed that DNA-PKcs was repressed in post-senescence MSC compared to pre-senescence MSC and a downregulation of Rad51 after senescence bypass, although expression was restored and upregulated after crisis bypass in TMC ([Figure 2C](#pone-0001398-g002){ref-type="fig"}).

![DNA repair regulation.\
(A) *x-fold* change, p-value and Z-score of DNA repair-related gene expression measured by microarray analysis between pre- and post-senescence MSC and post-senescence MSC and TMC. (B) Relative mRNA expression of ERCC3, DNA ligase IV (LIG IV), DNA polymerase β (POLβ) and μ (POLμ), RAD51, XPA and XRCC4 in pre- and post-senescence MSC, TMC and met-TMC analyzed by qRT-PCR. (C) Western blot analysis of DNA repair-related protein expression in pre- and post-senescence MSC and two TMC samples. α-tubulin was used as loading control.](pone.0001398.g002){#pone-0001398-g002}

In contrast, mRNA levels were modulated differentially between TMC and pre-senescence MSC for several DNA repair-associated proteins. Specifically, DNA-PKcs and PCNA were upregulated in TMC, and XPA was downregulated compared to pre-senescence MSC. Although DNA polymerase μ and ERCC3 upregulation were statistically significant, differences in mRNA levels appeared to be minor, based on *x*-fold change and Z-score values ([Figure 2A](#pone-0001398-g002){ref-type="fig"}).

We performed qRT-PCR experiments to validate microarray results. No modulation of expression of DNA repair-related genes was detected between pre- and post-senescence MSC. In contrast, several of these genes were overexpressed in TMC, such as DNA-PKcs, DNA polymerase μ, RAD51 or ERCC4 ([Figure 2B](#pone-0001398-g002){ref-type="fig"}).

We evaluated the correlation between RNA and protein levels by western blot analysis. Proteins were elevated in nearly all DNA repair pathways in TMC compared to pre-senescence MSC. These effects were protein- rather than pathway-specific. MMR was the only pathway that showed no differences between MSC and TMC, although we analyzed only PCNA in this pathway ([Figure 2C](#pone-0001398-g002){ref-type="fig"}).

Changes in tumor suppressors and oncogenes expression related with MSC transformation {#s2d}
-------------------------------------------------------------------------------------

To explore the role of tumor suppressor gene inactivation in MSC senescence and crisis bypass, we analyzed p16, p21 and p53. In a microarray screening assay, we found no changes in p21 or p53 levels, whereas MSC expressed less p16 mRNA after senescence bypass ([Figure 3A](#pone-0001398-g003){ref-type="fig"}), concurring with reports of a role for p16 in senescence induction [@pone.0001398-Jacobs1]. p16 downregulation was more marked when we compared TMC and pre-senescence MSC mRNA levels, and we found slight but significant p21 downregulation. We detected no differences in p53 mRNA ([Figure 3A](#pone-0001398-g003){ref-type="fig"}).

![Regulation of oncogenes and tumor suppressor genes.\
(A) *x-fold* change, p-value and Z-score of oncogenes and tumor suppressor genes measured by microarray analysis between pre- and post-senescence MSC and post-senescence MSC and TMC. (B) Relative mRNA expression of p16 analyzed by qRT-PCR in different samples of pre-senescence MSC (n = 4), post-senescence MSC (n = 3) and TMC (n = 3). (C) Homozygous deletion analysis of p14, p15 (D) and p16 (E) genes. β-actin was used as internal PCR control. Control cell lines were normal lymphocytes (NL), HCT116 and MDA-MB231. (F) Western blot analysis of p21 expression in pre- and post-senescence MSC, TMC and met-TMC. α-tubulin was used as loading control. (G) Analysis of p53 activation following UV irradiation of cells. p53 levels and phosphorylation were tested in pre- and post-senescence MSC, in two TMC samples and a sample of met-TMC. α-tubulin was used as loading control. (H) Rb protein levels and phosphorylation tested in pre- and post-senescence MSC, two samples of TMC and a met-TMC sample. α-tubulin was used as loading control.](pone.0001398.g003){#pone-0001398-g003}

To validate the microarray results, we used qRT-PCR to compare mRNA levels among the three cell types. p16 mRNA levels were downregulated in post-senescence MSC, to approximately 60% of the pre-senescence level. We observed no p16 mRNA amplification in TMC samples ([Figure 3B](#pone-0001398-g003){ref-type="fig"}). p16 protein is downregulated in post-senescence MSC, and absent in TMC [@pone.0001398-Rubio1], concurring with these results. We analyzed whether complete p16 repression in TMC was caused by promoter methylation, as reported for this tumor suppressor [@pone.0001398-Mund1], [@pone.0001398-Xing1] studying the methylation status. Methylation analysis of the Ink4a/Arf promoter showed no methylation (not shown). We used specific DNA-PCR to detect homozygous deletion of p14, p15 and p16, and found no amplification ([Figure 3C--E](#pone-0001398-g003){ref-type="fig"}), indicating that the Ink4A/Arf locus is deleted specifically in TMC.

Microarray analysis suggested slight p21 downregulation in TMC compared to pre-senescence MSC, with no difference between pre- and post-senescence MSC. We found no changes in p21 levels in western blot analysis of these populations ([Figure 3F](#pone-0001398-g003){ref-type="fig"}). Although p53 pathway defects have been associated with the generation of many tumor types [@pone.0001398-Sherr1], this pathway appeared to be functional in our stem cell transformation model, as p53 was upregulated after UV irradiation and was phosphorylated in all samples tested ([Figure 3G](#pone-0001398-g003){ref-type="fig"}). Basal p53 protein levels were also higher in TMC than in pre- or post-senescence MSC.

Finally, we assayed Rb levels and phosphorylation in pre- and post-senescent MSC, two TMC samples and a met-TMC sample. Rb protein levels were upregulated in TMC and met-TMC compared to pre- and post-senescence MSC. Rb phosphorylation increased progressively through the sequence of steps in TMC generation, and was slightly downregulated in met-TMC compared to TMC ([Figure 3H](#pone-0001398-g003){ref-type="fig"}).

We compared mRNA regulation differences in the oncogenes c-myc and telomerase in post-senescence MSC and TMC with pre-senescence MSC. We found no differences in oncogene mRNA transcript levels in these populations ([Figure 3A](#pone-0001398-g003){ref-type="fig"}). Nonetheless, in a previous publication we have shown that c-myc protein overexpression is linked to senescence bypass and is maintained in TMC; moreover, TMC also have telomerase activity which is not found in pre- or post-senescence MSC [@pone.0001398-Rubio1].

Discussion {#s3}
==========

Mesenchymal stem cells can be easily isolated and expanded in culture to generate large numbers of cells for cellular therapies. Human MSC in early passage are safe although stressful conditions (as they are cultured for a long time) can turn them in immortal and occasionally they became tumorogenic [@pone.0001398-Rubio1]. Further research is necessary to understand this process in order to develop better protocols for culture adult stem cells, as it has been demanded recently [@pone.0001398-Prockop1]. Here, we describe several molecular alterations in our spontaneous human MSC transformation model that affect cell cycle regulation, oncogene expression, mitochondrial metabolism, DNA repair mechanisms and inactivation of tumor suppressor genes.

TMC versus pre-senescence MSC array analysis showed that functions with a higher significance are related, as expected, with transformation, genetic disorders and cell death ([Table 1](#pone-0001398-t001){ref-type="table"}). We described previously that post-senescence MSC are non-tumorigenic and their cellular behaviour in culture was very similar to pre-senescence MSC [@pone.0001398-Rubio1]. Interestingly, post-senescence MSC versus pre-senescence MSC array analysis also showed the same functions altered than TMC, although in smaller grade ([Table 1](#pone-0001398-t001){ref-type="table"}), suggesting a pre-tumoral state of pre-senescence MSC.

We observed expression of many untranslated RNAs in MSC concurring with reports which show a large and "silent" mRNA pool in stem cells [@pone.0001398-Tremain1], this could be the reason why, following MSC transformation, we identified more downregulated than upregulated genes in arrays experiments ([Figure S1](#pone.0001398.s001){ref-type="supplementary-material"}). Comparison of mRNA and protein expression in pre- and post-senescence MSC and in TMC showed variation in RNA and protein regulation. Cyclin D2, Cdk1 and PCNA mRNA were upregulated in TMC compared to MSC, although their protein levels did not change; whereas c-Myc, Cdk2, Cdk6, DNA ligase IV and DNA polymerases mRNA levels remained stable but their protein levels were upregulated. Translational control could thus be important for adult stem cells, and retention of large numbers of silenced transcripts might allow rapid stem cell differentiation to other lineages in response to appropriate stimuli. These data also indicates the limitations of results based on RNA-exclusive analysis of MSC.

Telomerase activity has been found in almost all human tumors but not in adjacent normal cells [@pone.0001398-Kim1] and maintenance of telomere stability is required for the long-term proliferation of tumor cells [@pone.0001398-Shay1]. The escape from cellular senescence and thus becoming immortal by activating telomerase is required by most tumor cells for their ongoing proliferation [@pone.0001398-Shay2]. In our model, during TMC generation these cells acquire a detectable telomerase activity [@pone.0001398-Rubio1]. Telomerase promotes MSC immortalization and, in conjunction with additional events, produces cell transformation [@pone.0001398-Funes1], [@pone.0001398-Serakinci1], [@pone.0001398-Serakinci2]. These additional events usually implied an oncogene deregulation.

One of the most important oncogenes involved in MSC transformation is c-myc. In our spontaneous model, senescent and post-senescence MSC, as well as TMC, overexpress c-myc [@pone.0001398-Rubio1]. Consistent with our previous results, data from other groups have shown that c-myc seems to be essential to spontaneously transform MSC [@pone.0001398-Miura1], [@pone.0001398-Wang1], [@pone.0001398-Zhou1]. In this regard, Funes et al. used retroviral vectors to introduce human telomerase (TERT), HVP-16 E6 and E7, H-Ras and SV40 small T antigen (ST), individually or in combination, in human MSC. The combination of TERT, E6, E7 and H-Ras did not induce MSC transformation. Only MSC transduced with ST becomes transformed cells [@pone.0001398-Zhou1]. ST inactivates phosphatase 2A, resulting in c-myc stabilization [@pone.0001398-Yeh1], suggesting that c-myc might be necessary to transform MSC.

We explored DNA repair mechanisms to elucidate their role in MSC transformation. Post-senescent MSC showed downregulation of DNA-PKcs, ERCC3 and Rad51 proteins, each of which is associated to a distinct DNA repair pathway. Extremely restricted clonal selection takes place during cell crisis, and only cells with functional DNA repair mechanisms would continue to grow. TMC have a higher metabolic rate and divide more rapidly than pre- or post-senescence MSC, with a consequent increase in DNA damage. Proteins that participate in DNA repair are upregulated in TMC compared to MSC; this, together with telomere length maintenance, could permit cell survival, despite oxidative damage to DNA and be responsible for TMC karyotype stabilization. Recently it has been published the dependency on oxidative phosphorylation during MSC transformation [@pone.0001398-Li1]. We have not detected statistically significant changes of these genes in our microarray experiments ([Table S1](#pone.0001398.s002){ref-type="supplementary-material"}), although potential pathways leading to changes in post-senescence MSC and TMC revealed change in stress, toxic events and mitochondrial metabolism pathways ([Table 2](#pone-0001398-t002){ref-type="table"}). The definitive role of mitochondrial respiration on spontaneous MSC transformation remains to be investigated.

A chromosome 5 alteration and a (3;11) translocation are recurrent, stable features of *in vitro* cultured TMC [@pone.0001398-Rubio1]. The telomerase gene map to human chromosome 5, suggests that it is activated by internal amplification of this chromosome in TMC. Chromosome 11 alterations are recurrent in tumors [@pone.0001398-Daser1]. Although we did not detect a target gene in the 3;11 translocation in our model, genes involved in cell transformation are likely to be located in this region [@pone.0001398-Daibata1]--[@pone.0001398-Kourlas1].

As tumor suppressor genes are major targets in neoplastic transformation, we analyzed their expression in these cells. The tumor suppressor Rb is implicated in several cancer types [@pone.0001398-Sherr1]. In our model of MSC transformation, Rb protein levels are upregulated progressively, and Rb is inactivated by a phosphorylation mechanism in TMC, as described [@pone.0001398-Chau1]. In addition of Rb, loss of p53 function is common in many tumor types [@pone.0001398-Sherr1], but this pathway appeared to be functional in our model, as p53 was upregulated and phosphorylated in UV-irradiated cells. We observed higher basal p53 levels in TMC than in MSC, even when they had not been exposed to UV irradiation. In TMC, p16 mRNA and protein were entirely absent, and the Ink4a/Arf locus had been deleted. The increase in basal p53 may thus be due to stabilization by the ubiquitin protein ligase MDM2, due to the lack of p16 [@pone.0001398-Gorgoulis1]. Identical results, p16 locus deletion and normal p53 activity, was detected in telomerase-immortalized human MSC [@pone.0001398-Burns1]. The results suggest that p16 inhibition is essential for TMC generation, as is the case for human malignancies including glioblastoma, melanoma, pancreatic adenocarcinoma, non-small cell lung cancer, bladder carcinoma and oropharyngeal cancer, where this tumor suppressor is frequently lost [@pone.0001398-Sharpless1].

Finally, we propose a two-stage model in which a mesenchymal stem cell becomes a tumor cell ([Figure 4](#pone-0001398-g004){ref-type="fig"}). The first step, the senescence bypass or M1 phase, is associated with c-myc overexpression and p16 repression; many DNA repair proteins are subsequently downregulated. Telomere shortening provokes the cell crisis phase, or M2, in which cells undergo stringent selection. TMC then upregulate many DNA repair proteins, which may be necessary for crisis bypass. Finally, escape from crisis is associated with telomere stabilization, Rb hyperphosphorylation and p16 deletion that seems to be essential to promote transformation [@pone.0001398-Sharpless1], [@pone.0001398-Matheu1]. TMC also upregulate many DNA repair proteins, which may be necessary for crisis bypass. These levels are maintained in TMC and could permit cell survival, despite oxidative damage to DNA.

![Model of spontaneous human MSC transformation.\
Sequence of steps: morphologic, karyotypic, and molecular alterations during TMC generation. Black and blue boxes represent chromosomes, orange boxes represent telomeres.](pone.0001398.g004){#pone-0001398-g004}

The essential steps in TMC generation described here are basically in agreement with results of other authors working in MSC transformation [@pone.0001398-Miura1]--[@pone.0001398-Li1], [@pone.0001398-Burns1] and these alterations are very similar to molecular changes associated with transformation of other cell types. In epithelial cells, spontaneous immortalization of human keratinocytes exhibited a small number of chromosomal aberrations, reduced p^16INK4a^mRNA, elevated telomerase activity and functionally normal p53 [@pone.0001398-Rea1]. Immortalization of human prostate cells by c-myc stabilizes telomere length through up-regulation of TERT expression and lack Rb/p16^INK4a^ checkpoint, being easily transformed [@pone.0001398-Gil1]. In mesodermic cells, fibroblast cell lines immortalized either spontaneously or radio-chemically induced maintaining their telomerase activity, displayed loss of expression of p16^INK4a^ and hyperphosphorylation of Rb [@pone.0001398-Tsutsui1]. Telomerase-immortalized human fibroblast revealed overexpression of the c-myc and Bmi-1 oncogenes, as well as loss of p14^ARF^ expression [@pone.0001398-Milyavsky1], [@pone.0001398-Zongaro1], while overexpression of c-myc immortalizes freshly isolated human foreskin fibroblasts displayed a marked decrease in expression of p14^ARF^ [@pone.0001398-Benanti1].

In sum, all these evidences strongly suggest that cells with a mesodermal origin could require a common sequence of oncogenic events to become a tumor cells. How these processes are coordinated or associated with the critical cell evolution/selection revealed in the culture [@pone.0001398-Rubio1] remains to be studied in deep. In addition, the cause/consequence relationship of this molecular signature with the recently characterized mesenchymal to epithelial transition (Rubio, D. et al, in press) or other potentially involved mechanisms remains also to be determined.

Materials and Methods {#s4}
=====================

Isolation of MSC and cell culture {#s4a}
---------------------------------

MSC were isolated as described [@pone.0001398-Rubio1]. Briefly, adipose tissue from non-oncogenic patients were digested with collagenase P and cultured (37°C, 5% CO~2~) in MSC medium (DMEM plus 10% FCS, 2 mM glutamine, 50 µg/ml gentamycin) and passaged when they reached 85% confluence. TMC and met-TMC were cultured under the same conditions.

Microarray labeling {#s4b}
-------------------

Total RNA was isolated from four biological replicates of pre- and post-senescence MSC and from TMC using TriReagent Solution (Sigma) following manufacturer\'s instructions. RNAs were purified with MegaClear (Ambion) and integrity confirmed using the Agilent 2100 Bioanalyzer (Agilent Technologies). Total RNA (1.5 µg each) was amplified using the Amino Allyl MessageAmp aRNA kit (Ambion); we obtained 15--60 µg of amino-allyl amplified RNA (aRNA). Mean aRNA size was 1500 nucleotides, as measured using the Agilent 2100 Bioanalyzer. For each sample, 2.5 µg of aRNA was labeled with one aliquot of Cy3 or Cy5 Mono NHS Ester (CyDye Post-labeling Reactive Dye, Amersham) and purified with the Amino Allyl MessageAmp aRNA kit. Cy3 and Cy5 incorporation were measured using 1 µl probe in a Nanodrop spectrophotometer (Nanodrop Technologies). For each hybridizations, 80--100 pmol of Cy3 and Cy5 probes were mixed, dried by speed-vacuum, and resuspended in 9 µl RNase-free water. Labeled aRNA was fragmented by adding 1 µl of 10× fragmentation buffer (Ambion) and incubating (70°C, 15 min). The reaction was terminated with 1 µl stop solution (Ambion).

Slide treatment and hybridization {#s4c}
---------------------------------

Slides containing 22,102 annotated genes corresponding to the Human 70-mer oligo library (V2.2) (Qiagen-Operon) were obtained from the Genomics and Microarray Laboratory (Cincinnati University). Information on printing and the oligo set can be found at <http://microarray.uc.edu>. Slides were prehybridized (42°C, 45--60 min) in 6× SSC, 0.5% SDS and 1% BSA, then rinsed 10 times with distilled water. Fragmented Cy5 and Cy3 aRNA probes were mixed (80--100 pmol of each label) with 10 µg PolyA (Sigma) and 5 µg Human Cot-DNA (Invitrogen) and dried in a speed-vacuum. Each probe mix was resuspended in 60 µl of hybridization buffer (50% formamide, 6× SSC, 0.5% SDS, 5× Denhardt\'s solution). Probes were denatured (95°C, 5 min) and applied to the slide using a LifterSlip (Erie Scientific). Slides were incubated (48°C, 16 h) in hybridization chambers (Array-It; Telechem International) in a water bath. After incubation, slides were washed twice with 0.5× SSC, 0.1% SDS (5 min each), three times with 0.5× SSC (5 min) and finally in 0.05× SSC (5 min), then dried by centrifugation (563 g, 1 min). Images from Cy3 and Cy5 channels were equilibrated and captured with an Axon 4000B scanner and spots quantified using GenePix 5.1 software.

Four independent biological replicates were "dye swapped" and studied (8 hybridizations). Data were analyzed using Almazen software. Each replicate was lowess-normalized and the log ratios merged with the corresponding standard deviation and z-score. We obtained adjusted p-values using limma by FDR [@pone.0001398-Benanti1]. Differentially expressed genes were selected by filtering signal intensity (\>64), z-score (\>3.5 or \<−3.5) and p-value (\<0.01).

Pathways analysis {#s4d}
-----------------

By using Ingenuity Pathways Analysis (IPA), potential pathways leading to changes in MSC-postsenescence and TMC were created. This web-delivered application reveals relevant networks by comparing gene expression data with known pathways and interactions between genes (<http://www.ingenuity.com>). The filtered expression data set for MSC-postsenescence and TMC regulated genes were uploaded as tab-delimited text into IPA for generating biological networks. Each gene identifier was mapped to its corresponding object in the Ingenuity Pathways Knowledge Base. This software assigned a score for all networks that were ranked on the probability that a collection of genes equal to or greater than the number in a network could be achieved by chance alone (a score of 2 represents a 99% confidence level, and 3 a 99.9%). Biological functions are then calculated an assigned to each network

Quantitative real-time PCR (qRT-PCR) {#s4e}
------------------------------------

cDNA was generated from 100 ng of total RNA using the High Capacity cDNA Archive Kit (Applied Biosystems) in a 10 µl final reaction volume. Real-time PCR reactions were performed in triplicate using two dilutions (1/50, 1/500; 3 µl/well) of each cDNA, 1× TaqMan Assay-On-Demand (Hs00233365_m1, Cdkn2a; Hs00195591_m1, snail; Hs00161904_m1, slug) or primers described in [Table S2](#pone.0001398.s003){ref-type="supplementary-material"}, 1× SYBR Green PCR Master Mix or 1× TaqMan Universal PCR Master Mix (Applied Biosystems) in a volume of 8 µl in 384-well optical plates, or using Universal ProbeLibrary (Roche). PCR reactions were run on an ABI Prism 7900HT (Applied Biosystems) and SDS v2.2 software was used to analyze the results with the Comparative Ct Method (ΔΔCt).

Western blot {#s4f}
------------

Cell extracts were fractionated in 6%--15% SDS-PAGE, followed by transfer to PVDF membranes. We used antibodies to cyclins A clone E23 (1/200), D1 DCS-11 (1/1000), and D2 DCS-3.1 (1/1000) from Labvision; cyclin B1 sc-595 (1/200), cyclin D3 sc-182 (1/200), cdc2 sc-747 (1/200), cdk2 sc-163 (1/200), cdk4 sc-260 (1/200) and cdk6 sc-177 (1/200) were from Santa Cruz Biotechnology. DNA-PKcs Ab-1 (1/200) was from Calbiochem, and Ku-70 sc-9033 (1/200), XRCC4 sc-8285 (1/200), DNA ligase IV sc-11748 (1/200) were from Santa Cruz Biotechnology. We also used anti-DNA polymerase μ [@pone.0001398-Yeh1], -PCNA Ab-1 (Calbiochem, 1/100), and -DNA polymerase β Ab-1 (1/500), -ERCC1 Ab-2 (1/200), -XPA Ab-1 (1/200), -XPF Ab-1 (1/200), and -XPG Ab-1 (1/200) from Labvision, -Rad-51 (Pharmingen, 1/5000), -p21 sc-397 (Santa Cruz Biotechnology 1/1000), -p53 DO-1 (Merck, 1/1000), and -Rb (1/2000, overnight, 4°C), -phospho Ser 780-Rb (1/1000, overnight, 4°C), -phospho Ser 795-Rb (1/1000, overnight, 4°C), -phospho Ser 807/811-Rb (1/1000, overnight, 4°C) from Cell Signalling. We used anti-tubulin 9026 (Sigma, 1/5000). Incubation was 1 h at room temperature unless otherwise specified, followed by peroxidase-labelled goat anti-mouse, goat anti-rabbit or rabbit anti-goat antibody (Dako, 1/2000, 1 h, RT). Blots were developed using ECL (Amersham).

p53 activation assay {#s4g}
--------------------

We induced p53 upregulation and activation in UV-irradiated pre- and post-senescence MSC, TMC, and met-TMC (15 JU/m^2^). Extracts were collected 18 h after irradiation and used in western blot with anti-p53 or -phospho Ser15-p53 antibodies. α-tubulin was used as control.

Analysis of p16ink4a, p15ink4b and p14ARF CpG island methylation status {#s4h}
-----------------------------------------------------------------------

We determined DNA methylation patterns in the CpG islands of p16ink4a, p15ink4b and p14ARF tumor suppressor genes by chemical conversion of unmethylated, but not methylated, cytosine to uracil, followed by methyl-specific PCR (MSP) amplification using primers specific for methylated or modified unmethylated DNA [@pone.0001398-Wettenhall1], [@pone.0001398-Ruiz1]. Placental DNA treated *in vitro* with Sss I methyltransferase was used as positive control, and DNA from normal lymphocytes as negative control for methylated alleles. Each PCR sample (12 µl) was separated in non-denaturing 6% polyacrylamide gels, ethidium bromide-stained, and visualized with UV illumination. Promoter methylation status of these genes was verified by bisulfite genomic sequencing of CpG islands. Both strands were sequenced. Primers for bisulfite genomic sequencing and methylation-specific PCR were designed according to genomic sequences around presumed transcription start sites of the genes studied. Primer sequences and PCR conditions for methylation analysis are available on request.

Bisulfite treatment {#s4i}
-------------------

Genomic DNA was EcoRI-digested to shear DNA and achieve complete chemical conversion after bisulfite treatment. Sodium bisulfite conversion of genomic DNA (1 µg) was performed as described [@pone.0001398-Wettenhall1], [@pone.0001398-Ruiz1], with modifications. Briefly, NaOH was added to denature DNA (0.3 M final concentration) and incubated (15 min, 37°C). Fresh bisulfite solution (2.5 M sodium metabisulfite and 125 mM hydroquinone, pH 5.0) was added to each sample, and incubation continued (16 h, 50°C, in the dark). Modified DNA was purified using Wizard DNA purification resin (Promega) and eluted in water at 60°C. After desulfonation with NaOH (0.3 M final concentration; 10 min, 37°C), isolation was continued with 0.3 volume of 10.5 M ammonium acetate, followed by incubation (5 min, RT). Modified DNA was precipitated using 2.5 volumes of 100% ethanol and glycogen (5 mg/ml) as a carrier. The pellet was washed with 70% ethanol, dried, and eluted in distilled water.

Homozygous deletion analysis {#s4j}
----------------------------

We analyzed fragments of the p16INK4a-E1α, E2, p14ARF-E1β, and p15INK4b genes as described [@pone.0001398-Mund1] to detect homozygous deletion in TMC. Comparative multiplex PCR was performed as described [@pone.0001398-Herman1] to analyze each gene locus, using the β-actin fragment as internal control. Normal lymphocytes (NL) were used as negative control of tumor suppressor gene methylation, HCT116 (colorectal cancer line) as positive control of Ink4a/Arf locus methylation and MDA-MB231 (mammary adenocarcinoma) as control of Ink4a/Arf locus deletion.

Supporting Information {#s5}
======================
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Comparison of mRNA differences between pre- and post-senescence MSC and in TMC. Microarray analysis pattern of overall mRNA differences between pre- and post-senescence MSC (A), and pre-senescence MSC and TMC (B). MA plots are shown, being A: log-ratio of two expression intensities vs. M: the mean log-expression of the two.
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Main mRNA differences between pre-senescence MSC and TMC focused in genes implicated in bioenergetic pathways.
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Primers used for q-RT-PCR analysis with Universal ProbeLibrary protocol.
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